Westchester Capital Management (Nebraska)’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
CS
FCM
Westchester Capital Management (Nebraska)'s AGN Position: Q1 2020 in Review
Westchester Capital Management (Nebraska) sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 18,732 shares — an estimated $3.58M sold.
Westchester Capital Management (Nebraska) first reported a position in AGN in Q2 2015 and held it in 19 quarters. The position peaked at $8.71M in Q4 2015. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.
- Westchester Capital Management (Nebraska) reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
- Westchester Capital Management (Nebraska) sold 18,732 Allergan plc shares in Q1 2020, an estimated $3.58M.
- Westchester Capital Management (Nebraska) first reported a position in Allergan plc in Q2 2015 and held it in 19 quarters.
- Westchester Capital Management (Nebraska)'s Allergan plc position peaked at $8.71M in Q4 2015.
- 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.
Based on Westchester Capital Management (Nebraska)'s 13F filing for Q1 2020, filed 1 May 2020.